SAN DIEGO, Sep 07, 2010 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that the company will webcast its presentations at two upcoming investment conferences.
Illumina will webcast its presentation at the Morgan Stanley Global Healthcare Conference in New York, NY, on Tuesday, September 14, 2010. The live webcast is scheduled to begin at 8:35 a.m. ET and will feature a brief overview of the company by Christian Henry, Senior Vice President, Chief Financial Officer and General Manager of Life Sciences, followed by a question and answer session.
Illumina will webcast its presentation at the UBS Global Life Sciences Conference in New York, NY, on Tuesday, September 21, 2010. The live webcast is scheduled to begin at 8:00 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer.
These live webcasts can be accessed under the "Corporate/Investor Information" tab of Illumina's web site at http://www.illumina.com.
About Illumina
Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
SOURCE: Illumina, Inc.
Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
+858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Sr. Manager, Public Relations
+858-882-6822
wgrabill@illumina.com
